Products for Research Use Only
RegisterLogin

Lasofoxifene Tartrate

CAT: 0957-S9520-25mgSize: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S9520-25mgSize:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
190791-29-8
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Smiles
C1CCN (C1) CCOC2=CC=C (C=C2) C3C (CCC4=C3C=CC (=C4) O) C5=CC=CC=C5.C (C (C (=O) O) O) (C (=O) O) O
Molecular Formula
C32H37NO8
Additionnal Information
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM) which binds with high affinity to the human estrogen receptor-α with IC50 value of 1.5 nM.
Storage Conditions
3 years -20°C powder

Chemical Information

Lasofoxifene tartrate

Lasofoxifene Tartrate is the tartrate salt form of lasofoxifene, a non-steroidal, naphthalene-derived, third-generation selective estrogen receptor modulator (SERM) with potential antineoplastic and anti-osteoporotic activities. Upon oral administration, lasofoxifene selectively binds to both estrogen receptor alpha (ERalpha; ESR1) and estrogen receptor beta (ERbeta; ESR2) with high affinity and mimics the effects of endogenous estradiol with varying agonist and antagonist effects in ER-expressing tissues. Blockade of ERalpha by lasofoxifene may potentially inhibit estrogen-dependent cancer cell proliferation in ER-expressing cancers. Lasofoxifene may also bind to the certain mutant forms of ERalpha, including the Y537S ESR1 mutant, making it potentially useful in the treatment of tumors that have acquired resistance to other ER-targeting agents.

CAS Number190791-29-8
PubChem CID3081919
IUPAC Name(2S,3S)-2,3-dihydroxybutanedioic acid;(5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol
Molecular FormulaC32H37NO8
Molecular Weight563.6
Topological Polar Surface Area148
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Heavy Atom Count41
Formal Charge0
Complexity667
SMILES
C1CCN(C1)CCOC2=CC=C(C=C2)[C@H]3[C@H](CCC4=C3C=CC(=C4)O)C5=CC=CC=C5.[C@H]([C@@H](C(=O)O)O)(C(=O)O)O
InChI
InChI=1S/C28H31NO2.C4H6O6/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29;5-1(3(7)8)2(6)4(9)10/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2;1-2,5-6H,(H,7,8)(H,9,10)/t26-,28+;1-,2-/m10/s1
InChIKey
INEHJXCWEVNEDZ-LUDNRVPPSA-N
Chemical Structure
2D Structure
2D structure of Lasofoxifene tartrate
CAS: 190791-29-8
CID: 3081919
Formula: C32H37NO8
MW: 563.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight563.6
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass563.25191714
Monoisotopic Mass563.25191714
Topological Polar Surface Area148 Ų
Heavy Atom Count41
Formal Charge0
Complexity667
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
E7908Lasofoxifene
E7908-5mgLasofoxifene
S8183-01Pimavanserin tartrate
S3153-01Levalbuterol tartrate
E2964-100mgNorepinephrine tartrate
S8183-200mgPimavanserin tartrate
S8183-50mgPimavanserin tartrate
S8183-10mM/1mLPimavanserin tartrate
S2087-10mM/1mLRivastigmine Tartrate
S5217-25mgArformoterol Tartrate

Alternative Products

CatalogName
563056Lasofoxifene tartrate
HY-A0038-01Lasofoxifene (tartrate)
A18097-5Lasofoxifene Tartrate 5mg
A18097-100Lasofoxifene Tartrate 100mg
A18097-25Lasofoxifene Tartrate 25mg
A18097-10Lasofoxifene Tartrate 10mg
A18097-50Lasofoxifene Tartrate 50mg
A18097-10mM-DLasofoxifene Tartrate 10mM * 1mL in DMSO
281201-01Lasofoxifene

Popular Products